|
| ||||
| ||||
|
| ||||
| ||||
HORROR at Sea: Luxury Cruise Ship Infected With Deadly Virus Finally Docks
Wyatt’s Take A luxury cruise ship infected with deadly hantavirus has finally docked in Spain after passengers were trapped onboard with the dangerous disease The m/v Hondius arrived at the Canary Islands following what must have been a nightmare voyage for American tourists just trying to enjoy their vacation Another reminder that global health threats […]
Read More...
Yes here comes their next plandemic
For many people, chronic allergies do not begin all at once. It may start with seasonal pollen reactions for a few weeks out of the year. Then certain foods begin causing issues, then it becomes fragrances, mold, smoke, cleaning products, and the list goes on. At some point, you need to consider why your immune system cannot stop reacting. |
That’s exactly why my friend and respected colleague, Dr. Darin Ingels, is hosting a powerful new webinar on Low Dose Allergy (LDA) therapy. This approach goes beyond suppressing symptoms and focuses on retraining the immune system’s response over time. Instead of asking, “How do we cover this up?” LDA asks a much bigger question. “Why is the immune system reacting this way in the first place?” |
|
The tidal wave sparked by ‘The People vs. Poison’ rally is reshaping the conversation in Washington and beyond, as Del unpacks shifting alliances around food policy, chronic disease, and public trust. As pressure mounts on Anthony Fauci, we examine the growing legal questions surrounding his role in the COVID response, and why many believe he should be indicted. Plus, Dr. Tess Lawrie joins Del in studio with her investigation on whether the World Health Organization may still be influencing U.S. universities and public health systems—even after U.S. funding was halted. Guests: Dr. Tess Lawrie |
FEATURED ARTICLES |
Can You Actually Reverse Arterial Plaque? A Closer Look at the StudyBehind the Headlines |
| Nattokinase has been getting a lot of attention lately, and a big part of that traces back to a conversation between David Sinclair -- a Harvard-trained geneticist known for his work on aging biology -- and Peter Diamandis, founder of the XPRIZE Foundation and a prominent voice in exponential health technologies. Like most things that go viral, the nuance got left behind -- and what stuck was a single compelling idea: that arterial plaque might not be as permanent as we've been led to believe. |
THE TEN-DAY COUNTDOWN: "Please Delete This Email" - How Fauci's Own Words May Seal His Fate |
| With documentary evidence that goes to the heart of potential perjury, an active DNI investigation, and the architect of gain-of-function research now stripped of all federal funding, the statute of limitations deadline creates the perfect storm for long-overdue accountability. |
The human body is remarkably adaptable. It can compensate through poor sleep, chronic stress, processed food, environmental exposures, and years of low-level inflammation while continuing to function well enough that most people simply accept the symptoms that come with those issues. But adaptation is not always the same thing as health. Many chronic symptoms begin as compensation long before they become an obvious disease. And how far that compensation goes is the question that sits at the center of Body Burden: The Toxins We Carry. |
Rather than focusing on fear or headlines, Nick Pineault investigates what environmental medicine doctors are actually spending decades observing. He visited one of North America’s leading environmental medicine clinics with a film crew to document how these physicians evaluate toxic burden, what kinds of patterns they see repeatedly in patients, and whether meaningful recovery is possible when the body is finally given support instead of more strain. The documentary is less about catastrophic exposure and more about the hidden cost of constant adaptation. What price are you paying? |
So thankful that you're making an investment in your health, your life and yourself. Because health means everything, |